Skip to main content
Journal cover image

Evaluation of magnetic resonance imaging sensitivity in patients with relapsing remitting multiple sclerosis: baseline versus Betaseron treatment trials.

Publication ,  Journal Article
Frank, JA; Bash, C; Stone, L; Petrella, J; Maloni, H; McFarland, H
Published in: Acad Radiol
August 1996

Duke Scholars

Published In

Acad Radiol

DOI

ISSN

1076-6332

Publication Date

August 1996

Volume

3 Suppl 2

Start / End Page

S173 / S175

Location

United States

Related Subject Headings

  • Pentetic Acid
  • Organometallic Compounds
  • Nuclear Medicine & Medical Imaging
  • Nerve Fibers, Myelinated
  • Multiple Sclerosis
  • Middle Aged
  • Meglumine
  • Male
  • Magnetic Resonance Imaging
  • Interferon-beta
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Frank, J. A., Bash, C., Stone, L., Petrella, J., Maloni, H., & McFarland, H. (1996). Evaluation of magnetic resonance imaging sensitivity in patients with relapsing remitting multiple sclerosis: baseline versus Betaseron treatment trials. Acad Radiol, 3 Suppl 2, S173–S175. https://doi.org/10.1016/s1076-6332(96)80525-3
Frank, J. A., C. Bash, L. Stone, J. Petrella, H. Maloni, and H. McFarland. “Evaluation of magnetic resonance imaging sensitivity in patients with relapsing remitting multiple sclerosis: baseline versus Betaseron treatment trials.Acad Radiol 3 Suppl 2 (August 1996): S173–75. https://doi.org/10.1016/s1076-6332(96)80525-3.
Frank JA, Bash C, Stone L, Petrella J, Maloni H, McFarland H. Evaluation of magnetic resonance imaging sensitivity in patients with relapsing remitting multiple sclerosis: baseline versus Betaseron treatment trials. Acad Radiol. 1996 Aug;3 Suppl 2:S173–5.
Frank, J. A., et al. “Evaluation of magnetic resonance imaging sensitivity in patients with relapsing remitting multiple sclerosis: baseline versus Betaseron treatment trials.Acad Radiol, vol. 3 Suppl 2, Aug. 1996, pp. S173–75. Pubmed, doi:10.1016/s1076-6332(96)80525-3.
Frank JA, Bash C, Stone L, Petrella J, Maloni H, McFarland H. Evaluation of magnetic resonance imaging sensitivity in patients with relapsing remitting multiple sclerosis: baseline versus Betaseron treatment trials. Acad Radiol. 1996 Aug;3 Suppl 2:S173–S175.
Journal cover image

Published In

Acad Radiol

DOI

ISSN

1076-6332

Publication Date

August 1996

Volume

3 Suppl 2

Start / End Page

S173 / S175

Location

United States

Related Subject Headings

  • Pentetic Acid
  • Organometallic Compounds
  • Nuclear Medicine & Medical Imaging
  • Nerve Fibers, Myelinated
  • Multiple Sclerosis
  • Middle Aged
  • Meglumine
  • Male
  • Magnetic Resonance Imaging
  • Interferon-beta